Lowey Announces $1.6 Million Contract for New York Medical College for the Development of Flu Treatments05/13/14
Research seeks to expedite and increase flu vaccine production during high demand
WASHINGTON, D.C. - Congresswoman Nita M. Lowey (D-Westchester/Rockland), Ranking Democrat on the House Appropriations Committee, today announced a $1.6 million contract from the Biomedical Advanced Research and Development Authority (BARDA) to New York Medical College of Valhalla for research to develop new influenza vaccines.
"As the senior Democrat on the House Appropriations Committee, my highest priority is investing in initiatives that sustain a high quality of life for families in the Lower Hudson Valley," said Lowey. "This particular investment seeks to expedite and enlarge flu vaccine production, so that more and better vaccines are available quicker during high demand. This is a winning formula for strong communities and I will continue my work in Congress to ensure support for scientific research."
BARDA is the federal program that facilitates the development of vaccines, drugs, therapies, and diagnostic tools for public health emergencies.The influenza vaccine development project led by Dr. Doris Bucher at New York Medical College seeks to develop influenza vaccine seed strains optimized for high production yields and high immunogenicity.
Congresswoman Lowey, as Ranking Member of the House Appropriations Committee, has fought to increase investments in medical research. She is a longtime member of the subcommittee that funds medical research, and funding to National Institutes of Health has nearly tripled since she joined the committee.
This document was issued by Nita Lowey and was initially posted at lowey.house.gov. It was distributed, unedited and unaltered, by noodls on 2014-05-13 22:34:33. The original document issuer is solely responsible for the accuracy of the information contained therein.